Literature DB >> 17197004

Experimental tuberculosis in the European badger (Meles meles) after endobronchial inoculation of Mycobacterium bovis: I. Pathology and bacteriology.

L A L Corner1, E Costello, S Lesellier, D O'Meara, D P Sleeman, E Gormley.   

Abstract

The aim was to develop an endobronchial infection procedure for the study of Mycobacterium bovis infection in badgers. The badgers were anaesthetised and a cannula was passed per os to the tracheal bifurcation. When in place 1 ml of M. bovis suspension was inoculated. Three concentrations of M. bovis suspension were used; <10 colony forming units (cfu), approximately 10(2) cfu and approximately 3 x 10(3) cfu. The badgers were examined at three weekly intervals for clinical signs of disease and a tracheal aspirate was collected at each examination. The badgers were euthanased 17 weeks post infection (pi) and at the post mortem examination a wide range of tissues were examined for gross and histopathological lesions of tuberculosis and cultured for M. bovis. A sample of bronchial alveolar lavage (BAL) fluid was collected at post mortem for culture. At post mortem examination 17 weeks after infection, gross and histopathological lesions of tuberculosis were observed in all badgers inoculated with the high and medium dose and 1/3 inoculated with the low dose. M. bovis was recovered from all inoculated badgers. Infection in the high dose group was more widely disseminated than in the other groups. The number of sites with gross and histopathological lesions increased with increasing dose of M. bovis. All tracheal aspirates were negative on culture and only one BAL, collected from a badger of the high dose group, was positive on culture. No clinical signs due to the experimental infection were observed. The endobronchial route of inoculation is an effective route for establishing experimental infection, and could be used for studies of tuberculosis pathogenesis, immunology of M. bovis infection in badgers and for challenging badgers in vaccine protection studies. Badgers appeared to be very susceptible to infection by this procedure even with a dose of < 10 cfu but appear to control and limit the resulting infection.

Entities:  

Mesh:

Year:  2007        PMID: 17197004     DOI: 10.1016/j.rvsc.2006.10.016

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  11 in total

1.  Experimental model of tuberculosis in the domestic goat after endobronchial infection with Mycobacterium caprae.

Authors:  Bernat de Val Pérez; Sergio López-Soria; Miquel Nofrarías; Maite Martín; H Martin Vordermeier; Bernardo Villarreal-Ramos; Nadine Romera; Manel Escobar; David Solanes; Pere-Joan Cardona; Mariano Domingo
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

2.  Bacillus Calmette-Guérin vaccination reduces the severity and progression of tuberculosis in badgers.

Authors:  Mark A Chambers; Fiona Rogers; Richard J Delahay; Sandrine Lesellier; Roland Ashford; Deanna Dalley; Sonya Gowtage; Dipesh Davé; Si Palmer; Jacky Brewer; Timothy Crawshaw; Richard Clifton-Hadley; Steve Carter; Chris Cheeseman; Chris Hanks; Alistair Murray; Kate Palphramand; Stéphane Pietravalle; Graham C Smith; Alexandra Tomlinson; Neil J Walker; Gavin J Wilson; Leigh A L Corner; Stephen P Rushton; Mark D F Shirley; George Gettinby; Robbie A McDonald; R Glyn Hewinson
Journal:  Proc Biol Sci       Date:  2010-12-01       Impact factor: 5.349

3.  Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs.

Authors:  Olga Gil; Ivan Díaz; Cristina Vilaplana; Gustavo Tapia; Jorge Díaz; María Fort; Neus Cáceres; Sergio Pinto; Joan Caylà; Leigh Corner; Mariano Domingo; Pere-Joan Cardona
Journal:  PLoS One       Date:  2010-04-06       Impact factor: 3.240

4.  On-farm mitigation of transmission of tuberculosis from white-tailed deer to cattle: literature review and recommendations.

Authors:  W David Walter; Charles W Anderson; Rick Smith; Mike Vanderklok; James J Averill; Kurt C Vercauteren
Journal:  Vet Med Int       Date:  2012-09-06

5.  Optimising and evaluating the characteristics of a multiple antigen ELISA for detection of Mycobacterium bovis infection in a badger vaccine field trial.

Authors:  Inma Aznar; Klaas Frankena; Simon J More; Clare Whelan; Wayne Martin; Eamonn Gormley; Leigh A L Corner; Denise Murphy; Mart C M De Jong
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

6.  The Effect of Oral Vaccination with Mycobacterium bovis BCG on the Development of Tuberculosis in Captive European Badgers (Meles meles).

Authors:  Mark A Chambers; Frank Aldwell; Gareth A Williams; Si Palmer; Sonya Gowtage; Roland Ashford; Deanna J Dalley; Dipesh Davé; Ute Weyer; Francisco J Salguero; Alejandro Nunez; Allan K Nadian; Timothy Crawshaw; Leigh A L Corner; Sandrine Lesellier
Journal:  Front Cell Infect Microbiol       Date:  2017-01-24       Impact factor: 5.293

Review 7.  The role of badgers in the epidemiology of Mycobacterium bovis infection (tuberculosis) in cattle in the United Kingdom and the Republic of Ireland: current perspectives on control strategies.

Authors:  Deirdre Ní Bhuachalla; Leigh Al Corner; Simon J More; Eamonn Gormley
Journal:  Vet Med (Auckl)       Date:  2014-12-19

8.  Purification and Characterisation of Badger IgA and Its Detection in the Context of Tuberculosis.

Authors:  Deanna Dalley; Sandrine Lesellier; Francisco J Salguero; Mark A Chambers
Journal:  Vet Sci       Date:  2019-11-02

9.  Assessment of BCG and inactivated Mycobacterium bovis vaccines in an experimental tuberculosis infection model in sheep.

Authors:  Ana Balseiro; Raúl Altuzarra; Enric Vidal; Xavier Moll; Yvonne Espada; Iker A Sevilla; Mariano Domingo; Joseba M Garrido; Ramón A Juste; Miguel Prieto; Bernat Pérez de Val
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

Review 10.  Pathogenesis of Mycobacterium bovis Infection: the Badger Model As a Paradigm for Understanding Tuberculosis in Animals.

Authors:  Eamonn Gormley; Leigh A L Corner
Journal:  Front Vet Sci       Date:  2018-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.